Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04601493 · ClinicalTrials.gov registry record · NA
PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population
A NA study of Opioid Use Disorder and Opioid Use, sponsored by University of Minnesota.
- Completed
- Registry status
- NA
- Development phase
- 631
- Enrollment target
- 1
- Study location
NCT04601493: Completed NA study of Opioid Use Disorder and Opioid Use, sponsored by University of Minnesota.
NCT04601493 is a NA study of Opioid Use Disorder and Opioid Use that has completed, run by University of Minnesota. The registered enrollment target is 631 participants, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (86% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04601493, a NA study of Opioid Use Disorder and Opioid Use, has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- NA
- Development phase
- 631 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this research is to assess the effects of electronic health record (EHR)-based decision support tools on primary care provider (PCP) decision-making around pain treatment and opioid prescribing. The decision support tools are informed by principles of "behavioral economics," whereby clinicians are "nudged," though never forced, towards guideline-concordant care.
Primary Outcome
Outcome reported as the percent of Primary Care Appointments (PCAs) at each clinic during which an opioid is prescribed, without currently receiving a non-opioid alternative pain treatment (including a new order for a non-opioid pain treatment).
Conditions Studied
Interventions
- BEHAVIORAL Choice Architecture Nudge
- BEHAVIORAL PMP Integration & Nudge
Study Locations (1)
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 631 participants |
| Start Date | 2020-08-26 |
| Est. Completion | 2021-10-01 |
| Phase | NA |
What the finished NCT04601493 record still lists
NCT04601493 is an interventional study that assigns participants to a tested intervention. The registered 631 participants enrollment target is mid-sized for trials with a published cap, below the 4,654-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (86% lower).
The record links to 3 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 2 interventions - of which Choice Architecture Nudge is the first listed.
NCT04601493 reports a single indexed study location in Minnesota.
Frequently Asked Questions
What is clinical trial NCT04601493 about?
NCT04601493 is a clinical study titled "PRescribing INterventions for Chronic Pain Via the Electronic Health Record Study - Opioid-Naive Population". The objective of this research is to assess the effects of electronic health record (EHR)-based decision support tools on primary care provider (PCP) decision-making around pain treatment and opioid prescribing. The decision support tools are informed by principles of "behavioral economics," whereby...
What is the current status of trial NCT04601493?
This trial is currently completed. It is a NA study. The enrollment target is 631 participants. The study started on 2020-08-26. Estimated completion is 2021-10-01.
What conditions does trial NCT04601493 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Opioid Use, Opioid Abuse.
What interventions are being tested in trial NCT04601493?
The interventions under investigation include: Choice Architecture Nudge (BEHAVIORAL), PMP Integration & Nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT04601493?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04601493 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04601493's enrollment target sits among peer trials
631 26th of 257 higher than 232 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05744973 · 631 participants
Multi-level Predictors of Structural Racism and Discrimination and Associations With Health and Well-being Across the Life Course in Diverse Families
- NCT04704921 · 630 participants · Phase 2
Pivotal 1 Study of ABBV-RGX-314 (Also Known as RGX-314) Gene Therapy Administered Via Subretinal Delivery One Time in Participants With nAMD
- NCT04707729 · 630 participants · NA
ROX Index for the Timing of Intubation in Nasal High Flow
- NCT05061550 · 630 participants · Phase 2
Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI